1 1007 222 EFFECTS OF MINDFULNESS YOGA VS STRETCHING AND RESISTANCE TRAINING EXERCISES ON ANXIETY AND DEPRESSION FOR PEOPLE WITH PARKINSON DISEASE: A RANDOMIZED CLINICAL TRIAL. IMPORTANCE: CLINICAL PRACTICE GUIDELINES SUPPORT EXERCISE FOR PATIENTS WITH PARKINSON DISEASE (PD), BUT TO OUR KNOWLEDGE, NO RANDOMIZED CLINICAL TRIALS HAVE TESTED WHETHER YOGA IS SUPERIOR TO CONVENTIONAL PHYSICAL EXERCISES FOR STRESS AND SYMPTOM MANAGEMENT. OBJECTIVE: TO COMPARE THE EFFECTS OF A MINDFULNESS YOGA PROGRAM VS STRETCHING AND RESISTANCE TRAINING EXERCISE (SRTE) ON PSYCHOLOGICAL DISTRESS, PHYSICAL HEALTH, SPIRITUAL WELL-BEING, AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH MILD-TO-MODERATE PD. DESIGN, SETTING, AND PARTICIPANTS: AN ASSESSOR-MASKED, RANDOMIZED CLINICAL TRIAL USING THE INTENTION-TO-TREAT PRINCIPLE WAS CONDUCTED AT 4 COMMUNITY REHABILITATION CENTERS IN HONG KONG BETWEEN DECEMBER 1, 2016, AND MAY 31, 2017. A TOTAL OF 187 ADULTS (AGED >/=18 YEARS) WITH A CLINICAL DIAGNOSIS OF IDIOPATHIC PD WHO WERE ABLE TO STAND UNAIDED AND WALK WITH OR WITHOUT AN ASSISTIVE DEVICE WERE ENROLLED VIA CONVENIENCE SAMPLING. ELIGIBLE PARTICIPANTS WERE RANDOMIZED 1:1 TO MINDFULNESS YOGA OR SRTE. INTERVENTIONS: MINDFULNESS YOGA WAS DELIVERED IN 90-MINUTE GROUPS AND SRTE WERE DELIVERED IN 60-MINUTE GROUPS FOR 8 WEEKS. MAIN OUTCOMES AND MEASURES: PRIMARY OUTCOMES INCLUDED ANXIETY AND DEPRESSIVE SYMPTOMS ASSESSED USING THE HOSPITAL ANXIETY AND DEPRESSION SCALE. SECONDARY OUTCOMES INCLUDED SEVERITY OF MOTOR SYMPTOMS (MOVEMENT DISORDER SOCIETY UNIFIED PARKINSON'S DISEASE RATING SCALE [MDS-UPDRS], PART III MOTOR SCORE), MOBILITY, SPIRITUAL WELL-BEING IN TERMS OF PERCEIVED HARDSHIP AND EQUANIMITY, AND HRQOL. ASSESSMENTS WERE DONE AT BASELINE, 8 WEEKS (T1), AND 20 WEEKS (T2). RESULTS: THE 138 PARTICIPANTS INCLUDED 65 MEN (47.1%) WITH A MEAN (SD) AGE OF 63.7 (8.7) YEARS AND A MEAN (SD) MDS-UPDRS SCORE OF 33.3 (15.3). GENERALIZED ESTIMATING EQUATION ANALYSES REVEALED THAT THE YOGA GROUP HAD SIGNIFICANTLY BETTER IMPROVEMENT IN OUTCOMES THAN THE SRTE GROUP, PARTICULARLY FOR ANXIETY (TIME-BY-GROUP INTERACTION, T1: BETA, -1.79 [95% CI, -2.85 TO -0.69; P = .001]; T2: BETA, -2.05 [95% CI, -3.02 TO -1.08; P < .001]), DEPRESSION (T1: BETA, -2.75 [95% CI, -3.17 TO -1.35; P < .001]); T2: BETA, -2.75 [95% CI, -3.71 TO -1.79; P < .001]), PERCEIVED HARDSHIP (T1: BETA, -0.92 [95% CI, -1.25 TO -0.61; P < .001]; T2: BETA, -0.76 [95% CI, -1.12 TO -0.40; P < .001]), PERCEIVED EQUANIMITY (T1: BETA, 1.11 [95% CI, 0.79-1.42; P < .001]; T2: BETA, 1.19 [95% CI, 0.82-1.56; P < .001]), AND DISEASE-SPECIFIC HRQOL (T1: BETA, -7.77 [95% CI, -11.61 TO -4.38; P < .001]; T2: BETA, -7.99 [95% CI, -11.61 TO -4.38; P < .001]). CONCLUSIONS AND RELEVANCE: AMONG PATIENTS WITH MILD-TO-MODERATE PD, THE MINDFULNESS YOGA PROGRAM WAS FOUND TO BE AS EFFECTIVE AS SRTE IN IMPROVING MOTOR DYSFUNCTION AND MOBILITY, WITH THE ADDITIONAL BENEFITS OF A REDUCTION IN ANXIETY AND DEPRESSIVE SYMPTOMS AND AN INCREASE IN SPIRITUAL WELL-BEING AND HRQOL. TRIAL REGISTRATION: CENTRE FOR CLINICAL RESEARCH AND BIOSTATISTICS IDENTIFIER: CUHK_CCRB00522. 2019 2 1034 58 EFFECTS OF YOGA IN DAILY LIFE PROGRAM IN RHEUMATOID ARTHRITIS: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: TO EXPLORE THE FEASIBILITY AND EFFECTIVENESS OF A YOGA PROGRAM IN IMPROVING HEALTH-RELATED QUALITY OF LIFE (HQOL), PHYSICAL AND PSYCHOLOGICAL FUNCTIONING IN RHEUMATOID ARTHRITIS (RA) PATIENTS. DESIGN: SINGLE-CENTRE PARALLEL-ARMS RANDOMIZED CONTROLLED TRIAL COMPARING YOGA (N = 30) AND EDUCATION CONTROL GROUP (N = 27). SETTING: TERTIARY CARE UNIVERSITY HOSPITAL. INTERVENTION: A 12-WEEK YOGA PROGRAM, BASED ON THE YOGA IN DAILY LIFE SYSTEM, INCLUDED 2X WEEKLY/90-MINUTE SESSIONS. THE CONTROL GROUP HAD 1XWEEKLY/60-MINUTE EDUCATIONAL LECTURES ON ARTHRITIS-RELATED TOPICS. MAIN OUTCOME MEASURES: ASSESSMENTS WERE PERFORMED AT BASELINE, 12 (POST-INTERVENTION) AND 24 WEEKS (FOLLOW-UP). THE PRIMARY OUTCOME WAS CHANGE IN THE SHORT FORM-36 (SF-36) HQOL AT 12 WEEKS. LINEAR REGRESSION ANALYSIS WAS ADJUSTED FOR BASELINE SCORES. RESULTS: NO SIGNIFICANT BETWEEN-GROUP DIFFERENCES WERE FOUND FOR SF-36 (ALL P > 0.05). AT 12 WEEKS THE ADJUSTED MEAN DIFFERENCE BETWEEN GROUPS FAVOURED YOGA FOR FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY-FATIGUE (5.08 CI 1.29 TO 8.86; P = 0.009) AND HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS)-DEPRESSION (-1.37 CI -2.38 TO -0.36); P = 0.008) AND AT 24 WEEKS FOR HADS-ANXIETY (-1.79 CI -3.34 TO - 0.23; P = 0.025), WHILE THE IMPACT ON FATIGUE WAS SUSTAINED (5.43 CI 1.33 TO 9.54, P = 0.01). THE PROGRAM HAD NO IMPACT ON RA DISEASE ACTIVITY. FEASIBILITY OUTCOMES INCLUDED RECRUITMENT RATE 16 %, RETENTION 80.7 %, AND ADHERENCE TO YOGA 87.5 VS 82.7 % FOR CONTROL. NO SERIOUS ADVERSE EVENTS WERE RECORDED. CONCLUSIONS: YOGA IN DAILY LIFE PROGRAM WAS NOT ASSOCIATED WITH CHANGE IN HEALTH-RELATED QUALITY OF LIFE OF RA PATIENTS. SIGNIFICANT IMPROVEMENTS IN FATIGUE AND MOOD WERE OBSERVED AT POSTINTERVENTION AND FOLLOW-UP. THIS YOGA PROGRAM WAS FOUND FEASIBLE AND SAFE FOR PATIENTS AND MAY COMPLEMENT STANDARD RA TREAT-TO-TARGET STRATEGY. 2021 3 1006 68 EFFECTS OF MINDFULNESS YOGA VERSUS CONVENTIONAL PHYSICAL EXERCISES ON SYMPTOM EXPERIENCES AND HEALTH-RELATED QUALITY OF LIFE IN PEOPLE WITH PARKINSON'S DISEASE: THE POTENTIAL MEDIATING ROLES OF ANXIETY AND DEPRESSION. BACKGROUND: ALTHOUGH SEVERAL STUDIES HAVE REPORTED POSITIVE EFFECTS OF MIND-BODY EXERCISES ON SYMPTOM MANAGEMENT AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF PEOPLE LIVING WITH PARKINSON'S DISEASE (PD), IT IS NOT KNOWN WHETHER THESE EFFECTS ARE ATTRIBUTABLE TO A CHANGE IN ANXIETY AND DEPRESSION. PURPOSE: TO COMPARE THE EFFECTS OF MINDFULNESS YOGA TO CONVENTIONAL STRETCHING EXERCISES IN A RANDOMIZED CONTROLLED TRIAL WHILE EXAMINING POTENTIALLY MEDIATING EFFECTS OF ANXIETY AND DEPRESSION. METHODS: 138 ADULTS WITH PD WERE RANDOMIZED TO EIGHT WEEKLY YOGA (N = 71) OR STRETCHING (N = 67) SESSIONS. SYMPTOM EXPERIENCES, ANXIETY AND DEPRESSION, AND HRQOL OUTCOMES WERE ASSESSED AT BASELINE, IMMEDIATE POST-INTERVENTION, AND 3-MONTH POST-INTERVENTION. RESULTS: GENERALIZED ESTIMATING EQUATION ANALYSES REVEALED THAT, COMPARED TO STRETCHING, YOGA SIGNIFICANTLY IMPROVED PATIENTS' NONMOTOR (TIME-BY-GROUP INTERACTION, T1:BETA = -1.99, P = .008; T2:BETA = -2.86, P < .001) AND MOTOR (TIME-BY-GROUP INTERACTION, T1:BETA = -1.77, P = .03) SYMPTOM EXPERIENCES. THE MEDIATION ANALYSIS FOUND THAT THE CHANGES IN ANXIETY AND DEPRESSION WERE THE MEDIATORS IN THE ASSOCIATIONS BETWEEN NON-MOTOR EXPERIENCE AND HRQOL; WHILE ONLY THE CHANGES IN DEPRESSION WERE FOUND TO BE THE MEDIATOR IN THE RELATIONSHIP BETWEEN MOTOR EXPERIENCE AND HRQOL. CONCLUSIONS: YOGA IS SUPERIOR TO CONVENTIONAL STRETCHING EXERCISES IN IMPROVING NONMOTOR AND MOTOR SYMPTOMS IN DAILY LIVING. REDUCED ANXIETY AND DEPRESSION PLAY A ROLE IN MEDIATING THE POSITIVE EFFECTS OF THE MINDFULNESS YOGA INTERVENTION. TO OPTIMIZE HRQOL, REHABILITATION SHOULD REINFORCE PSYCHOLOGICAL CARE IN ADDITION TO PHARMACOLOGICAL TREATMENTS AND PHYSICAL RELIEF OF PD SYMPTOMS. FUTURE STUDIES ARE NEEDED TO IDENTIFY STRATEGIES FOR FACILITATING THE IMPLEMENTATION AND SUSTAINABILITY OF MIND-BODY REHABILITATION TO ENHANCE THE QUALITY OF CARE FOR PD. 2022 4 2187 61 THE EFFECTS OF YOGA ON STUDENT MENTAL HEALTH: A RANDOMISED CONTROLLED TRIAL. BACKGROUND: UNIVERSITIES AROUND THE WORLD ARE FACING AN EPIDEMIC OF MENTAL DISTRESS AMONG THEIR STUDENTS. THE PROBLEM IS TRULY A PUBLIC HEALTH ISSUE, AFFECTING MANY AND WITH SERIOUS CONSEQUENCES. THE GLOBAL BURDEN OF DISEASE-AGENDA CALLS FOR EFFECTIVE INTERVENTIONS WITH LASTING EFFECTS THAT HAVE THE POTENTIAL TO IMPROVE THE MENTAL HEALTH OF YOUNG ADULTS. IN THIS STUDY WE AIMED TO DETERMINE WHETHER YOGA, A POPULAR AND WIDELY AVAILABLE MIND-BODY PRACTICE, CAN IMPROVE STUDENT MENTAL HEALTH. METHODS: WE PERFORMED A RANDOMISED CONTROLLED TRIAL WITH 202 HEALTHY UNIVERSITY STUDENTS IN THE OSLO AREA. THE PARTICIPANTS WERE ASSIGNED TO A YOGA GROUP OR WAITLIST CONTROL GROUP IN A 1:1 RATIO BY A SIMPLE ONLINE RANDOMISATION PROGRAM. THE INTERVENTION GROUP WAS OFFERED 24 YOGA SESSIONS OVER 12 WEEKS. MEASUREMENTS WERE TAKEN AT WEEK 0 (BASELINE), WEEK 12 (POST-INTERVENTION), AND WEEK 24 (FOLLOW-UP). THE PRIMARY OUTCOME WAS PSYCHOLOGICAL DISTRESS ASSESSED BY THE HSCL-25 QUESTIONNAIRE. ANALYSIS WAS PERFORMED BASED ON THE INTENTION TO TREAT-PRINCIPLE. RESULTS: BETWEEN 24 JANUARY 2017, AND 27 AUGUST 2017, WE RANDOMLY ASSIGNED 202 STUDENTS TO A YOGA INTERVENTION GROUP (N = 100), OR WAITLIST CONTROL GROUP (N = 102). COMPARED WITH THE CONTROL GROUP, THE YOGA PARTICIPANTS DEMONSTRATED A SIGNIFICANT REDUCTION IN DISTRESS SYMPTOMS BOTH AT POST-INTERVENTION (ADJUSTED DIFFERENCE IN THE MEAN CHANGE -0.15, 95% CI -0.26 TO -0.03, P = 0.0110) AND FOLLOW-UP (ADJUSTED DIFFERENCE IN THE MEAN CHANGE -0.18, 95% CI -0.29 TO -0.06, P = 0.0025). SLEEP QUALITY ALSO IMPROVED AT POST-INTERVENTION AND FOLLOW-UP. NO ADVERSE EVENTS WERE REPORTED. CONCLUSIONS: OUR FINDINGS SUGGEST THAT YOGA HAS A MODERATELY LARGE AND LASTING EFFECT, AT LEAST FOR SOME MONTHS, REDUCING SYMPTOMS OF DISTRESS AND IMPROVING SLEEP QUALITY AMONG STUDENTS. FURTHER RESEARCH SHOULD SEEK WAYS TO ENHANCE THE EFFECT, ASSESS AN EVEN LONGER FOLLOW-UP PERIOD, INCLUDE ACTIVE CONTROL GROUPS, AND CONSIDER PERFORMING SIMILAR STUDIES IN OTHER CULTURAL SETTINGS.TRIAL REGISTRATION: CLINICALTRIALS.GOV IDENTIFIER: NCT04258540. 2020 5 1078 37 EFFECTS OF YOGA ON PSYCHOLOGICAL HEALTH IN OLDER ADULTS. BACKGROUND: THE OBJECTIVE OF THIS STUDY WAS TO ASSESS THE EFFECT OF A YOGA INTERVENTION ON PSYCHOLOGICAL HEALTH IN OLDER ADULTS. METHOD: A RANDOMIZED CONTROLLED TRIAL STUDY, CONDUCTED AT 2 NORTH FLORIDA FACILITIES FOR OLDER ADULTS. SUBJECTS WERE 98 OLDER ADULTS, AGES 65 TO 92. PARTICIPANTS WERE RANDOMLY ASSIGNED TO CHAIR YOGA, CHAIR EXERCISE, AND CONTROL GROUPS AND ASSESSED PREINTERVENTION, POSTINTERVENTION, AND 1-MONTH FOLLOW-UP ON THE STATE ANGER EXPRESSION INVENTORY, STATE ANXIETY INVENTORY, GERIATRIC DEPRESSION SCALE, LAWTON'S PGC MORALE SCALE, GENERAL SELF-EFFICACY SCALE, CHRONIC DISEASE SELF-EFFICACY SCALES, AND SELF- CONTROL SCHEDULE. RESULTS: YOGA PARTICIPANTS IMPROVED MORE THAN BOTH EXERCISE AND CONTROL PARTICIPANTS IN ANGER (COHEN'S D = 0.89 FOR YOGA VERSUS EXERCISE, AND 0.90 FOR YOGA VERSUS CONTROL, PRETEST TO POSTTEST; AND D = 0.90 AND 0.72, PRETEST TO FOLLOW-UP), ANXIETY (D = 0.27, 0.39 AND 0.62, 0.63), DEPRESSION (D = 0.47, 0.49 AND 0.53, 0.51), WELL-BEING (D = 0.14, 0.49 AND 0.25, 0.61), GENERAL SELF-EFFICACY (D = 0.63, 1.10 AND 0.30, 0.85), AND SELF-EFFICACY FOR DAILY LIVING (D = 0.52, 0.81 AND 0.27, 0.42). CHANGES IN SELF-CONTROL MODERATED CHANGES IN PSYCHOLOGICAL HEALTH. CONCLUSIONS: OVER A 6-WEEK PERIOD, OUR FINDINGS INDICATE YOGA'S POTENTIAL FOR IMPROVING PSYCHOLOGICAL HEALTH IN OLDER ADULTS. 2014 6 459 50 CHANGES IN PAIN INTENSITY AND HEALTH RELATED QUALITY OF LIFE WITH IYENGAR YOGA IN NONSPECIFIC CHRONIC LOW BACK PAIN: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: NONSPECIFIC CHRONIC LOW BACK (NCLBP) PAIN IS PREVALENT AMONG ADULT POPULATION AND OFTEN LEADS TO FUNCTIONAL LIMITATIONS, PSYCHOLOGICAL SYMPTOMS, LOWER QUALITY OF LIFE (QOL), AND HIGHER HEALTHCARE COSTS. THE PURPOSE OF THIS STUDY WAS TO DETERMINE THE EFFICACY OF IYENGAR YOGA THERAPY ON PAIN INTENSITY AND HEALTH RELATED QUALITY OF LIFE (HRQOL) WITH NCLBP. AIM OF THE STUDY: TO COMPARE THE EFFECT OF IYENGAR YOGA THERAPY AND CONVENTIONAL EXERCISE THERAPY ON PAIN INTENSITY AND HRQOL IN NONSPECIFIC CHRONIC LOW BACK PAIN. MATERIALS AND METHODS: EXPERIMENTAL STUDY WITH RANDOM SAMPLING TECHNIQUE. SUBJECTS/INTERVENTION: SIXTY SUBJECTS WHO FULFILLED THE SELECTION CRITERIA WERE RANDOMLY ASSIGNED TO IYENGAR YOGA (YOGA GROUP, N = 30) AND CONTROL GROUP (EXERCISE GROUP, N = 30). PARTICIPANTS COMPLETED LOW BACK PAIN EVALUATION FORM AND HRQOL-4 QUESTIONNAIRE BEFORE THEIR INTERVENTION AND AGAIN 4 WEEKS AND 6 MONTH LATER. YOGA GROUP UNDERWENT 29 YOGIC POSTURES TRAINING AND EXERCISE GROUP HAD UNDERGONE GENERAL EXERCISE PROGRAM FOR 4 WEEKS. STATISTICS: REPEATED MEASURES ANALYSIS OF VARIANCE (ANOVA) WAS USED TO ANALYZE GROUP DIFFERENCES OVER TIME, WHILE CONTROLLING FOR BASELINE DIFFERENCES. RESULTS: PATIENTS IN BOTH GROUPS EXPERIENCED SIGNIFICANT REDUCTION IN PAIN AND IMPROVEMENT IN HRQOL. IN VISUAL ANALOGUE SCALE (VAS) YOGA GROUP SHOWED REDUCTION OF 72.81% (P = 0.001) AS COMPARED TO EXERCISE GROUP 42.50% (P = 0.001). IN HRQOL, YOGA GROUP SHOWED REDUCTION OF 86.99% (P = 0.001) AS COMPARED TO EXERCISE GROUP 67.66% (P = 0.001). CONCLUSION: THESE RESULTS SUGGEST THAT IYENGAR YOGA PROVIDES BETTER IMPROVEMENT IN PAIN REDUCTION AND IMPROVEMENT IN HRQOL IN NONSPECIFIC CHRONIC BACK PAIN THAN GENERAL EXERCISE. 2014 7 1232 48 FEASIBILITY AND POTENTIAL BENEFITS OF PARTNER-SUPPORTED YOGA ON PSYCHOSOCIAL AND PHYSICAL FUNCTION AMONG LUNG CANCER PATIENTS. OBJECTIVE: PATIENTS WITH LUNG CANCER EXPERIENCE SIGNIFICANT DECLINES IN PSYCHOSOCIAL AND PHYSICAL FUNCTION DURING AND AFTER TREATMENT THAT IMPACT QUALITY OF LIFE (QOL) AND SURVIVAL. YOGA IS A POTENTIAL STRATEGY TO MITIGATE FUNCTIONAL DECLINE AMONG PATIENTS WITH LUNG CANCER. METHODS: A SINGLE GROUP 12-WEEK PILOT TRIAL OF LOW-MODERATE INTENSITY YOGA AMONG PATIENTS WITH STAGE I-IV LUNG CANCER AND THEIR PARTNERS (N = 46; 23 PATIENT-PARTNER DYADS) DURING CANCER TREATMENT FROM TWO HOSPITAL SYSTEMS. FEASIBILITY, ACCEPTABILITY, DESCRIPTIVE STATISTICS, AND COHEN D EFFECT SIZES WERE CALCULATED AT 6 AND 12-WEEKS FOR PSYCHOSOCIAL AND PHYSICAL OUTCOMES USING VALIDATED QUESTIONNAIRES AND ASSESSMENTS. RESULTS: AT 6 AND 12-WEEKS, RETENTION WAS 65% AND WITHDRAWALS WERE MAINLY DUE TO DISEASE PROGRESSION. AMONG STUDY COMPLETERS (N = 26; 13 DYADS) ADHERENCE WAS 80%. COMPARING BASELINE TO 12-WEEK MEASUREMENTS, FATIGUE, DEPRESSION SYMPTOMS, AND SLEEP DISTURBANCE IMPROVED IN 54% OF PARTICIPANTS FOR ALL THREE MEASURES (COHEN'S D = 0.40-0.53). QOL IMPROVED IN 77% OF PARTICIPANTS (COHEN'S D = 0.34). UPPER AND LOWER BODY FLEXIBILITY, AND LOWER BODY STRENGTH IMPROVED IN 92%, 85% AND 77% OF PARTICIPANTS, RESPECTIVELY (COHEN'S D = 0.39-1.08). SIX-MINUTE WALK TEST IMPROVED IN 62% OF PARTICIPANTS AN AVERAGE OF 32 METERS (SD = 11.3; COHEN'S D = 0.17). NO SERIOUS ADVERSE EVENTS WERE REPORTED. CONCLUSIONS: AMONG PATIENTS WITH STAGE I-IV LUNG CANCER INCLUDING ACTIVE TREATMENT, A 12-WEEK PARTNER-SUPPORTED YOGA PROGRAM IS FEASIBLE, ACCEPTABLE, AND IMPROVED PSYCHOSOCIAL AND PHYSICAL FUNCTION. LOW-INTENSITY YOGA MAY BE A COMPLIMENTARY APPROACH TO REDUCE THE EFFECTS OF CANCER TREATMENT, HOWEVER, MORE RESEARCH IS NEEDED TO DETERMINE THE EFFICACY OF PARTNER-SUPPORTED YOGA TO MITIGATE FUNCTIONAL DECLINE. 2021 8 430 70 CAN YOGA OR PHYSICAL THERAPY FOR CHRONIC LOW BACK PAIN IMPROVE DEPRESSION AND ANXIETY AMONG ADULTS FROM A RACIALLY DIVERSE, LOW-INCOME COMMUNITY? A SECONDARY ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: TO DETERMINE AND COMPARE THE EFFECT OF YOGA, PHYSICAL THERAPY (PT), AND EDUCATION ON DEPRESSIVE AND ANXIOUS SYMPTOMS IN PATIENTS WITH CHRONIC LOW BACK PAIN (CLBP). DESIGN: SECONDARY ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL. SETTING: ACADEMIC SAFETY NET HOSPITAL AND 7 COMMUNITY HEALTH CENTERS. PARTICIPANTS: A TOTAL OF 320 ADULTS WITH CLBP. INTERVENTION: YOGA CLASSES, PT SESSIONS, OR AN EDUCATIONAL BOOK. OUTCOME MEASURE: DEPRESSION AND ANXIETY WERE MEASURED USING THE PATIENT HEALTH QUESTIONNAIRE AND GENERALIZED ANXIETY DISORDER 7-ITEM SCALE, RESPECTIVELY, AT BASELINE, 12, AND 52 WEEKS. WE IDENTIFIED BASELINE AND MIDTREATMENT (6-WK) FACTORS ASSOCIATED WITH CLINICALLY MEANINGFUL IMPROVEMENTS IN DEPRESSIVE (>/=3 POINTS) OR ANXIOUS (>/=2 POINTS) SYMPTOMS AT 12 WEEKS. RESULTS: PARTICIPANTS (FEMALE=64%; MEAN AGE, 46.0+/-10.7 YEARS) WERE PREDOMINANTLY NON-WHITE (82%), LOW-INCOME (<$30,000/YEAR, 59%), AND HAD NOT RECEIVED A COLLEGE DEGREE (71%). MOST PARTICIPANTS HAD MILD OR WORSE DEPRESSIVE (60%) AND ANXIOUS (50%) SYMPTOMS. AT 12 WEEKS, YOGA AND PT PARTICIPANTS EXPERIENCED MODEST WITHIN-GROUP IMPROVEMENTS IN DEPRESSIVE SYMPTOMS (MEAN DIFFERENCE [MD]=-1.23 [95% CI, -2.18 TO -0.28]; MD=-1.01 [95% CI, -2.05 TO -0.03], RESPECTIVELY). COMPARED WITH THE EDUCATION GROUP, 12-WEEK DIFFERENCES WERE NOT STATISTICALLY SIGNIFICANT, ALTHOUGH TRENDS FAVORED YOGA (MD=-0.71 [95% CI, -2.22 TO 0.81]) AND PT (MD= -0.32 [95% CI, -1.82 TO 1.18]). AT 12 WEEKS, IMPROVEMENTS IN ANXIOUS SYMPTOMS WERE ONLY FOUND IN PARTICIPANTS WHO HAD MILD OR MODERATE ANXIETY AT BASELINE. INDEPENDENT OF TREATMENT ARM, PARTICIPANTS WHO HAD 30% OR GREATER IMPROVEMENT IN PAIN OR FUNCTION MIDTREATMENT WERE MORE LIKELY TO HAVE A CLINICALLY MEANINGFUL IMPROVEMENT IN DEPRESSIVE SYMPTOMS (ODDS RATIO [OR], 1.82 [95% CI, 1.03-3.22]; OR, 1.79 [95% CI, 1.06-3.04], RESPECTIVELY). CONCLUSIONS: IN OUR SECONDARY ANALYSIS WE FOUND THAT DEPRESSION AND ANXIETY, COMMON IN THIS SAMPLE OF UNDERSERVED ADULTS WITH CLBP, MAY IMPROVE MODESTLY WITH PT AND YOGA. HOWEVER, EFFECTS WERE NOT SUPERIOR TO EDUCATION. IMPROVEMENTS IN PAIN AND FUNCTION ARE ASSOCIATED WITH A DECREASE IN DEPRESSIVE SYMPTOMS. MORE RESEARCH IS NEEDED TO OPTIMIZE THE INTEGRATION OF PHYSICAL AND PSYCHOLOGICAL WELL-BEING IN PT AND YOGA. 2021 9 290 49 ADJUNCTIVE YOGA V. HEALTH EDUCATION FOR PERSISTENT MAJOR DEPRESSION: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: THE OBJECTIVE OF THIS STUDY WAS TO DETERMINE WHETHER HATHA YOGA IS AN EFFICACIOUS ADJUNCTIVE INTERVENTION FOR INDIVIDUALS WITH CONTINUED DEPRESSIVE SYMPTOMS DESPITE ANTIDEPRESSANT TREATMENT. METHOD: WE CONDUCTED A RANDOMIZED CONTROLLED TRIAL OF WEEKLY YOGA CLASSES (N = 63) V. HEALTH EDUCATION CLASSES (HEALTHY LIVING WORKSHOP; HLW; N = 59) IN INDIVIDUALS WITH ELEVATED DEPRESSION SYMPTOMS AND ANTIDEPRESSANT MEDICATION USE. HLW SERVED AS AN ATTENTION-CONTROL GROUP. THE INTERVENTION PERIOD WAS 10 WEEKS, WITH FOLLOW-UP ASSESSMENTS 3 AND 6 MONTHS AFTERWARDS. THE PRIMARY OUTCOME WAS DEPRESSION SYMPTOM SEVERITY ASSESSED BY BLIND RATER AT 10 WEEKS. SECONDARY OUTCOMES INCLUDED DEPRESSION SYMPTOMS OVER THE ENTIRE INTERVENTION AND FOLLOW-UP PERIODS, SOCIAL AND ROLE FUNCTIONING, GENERAL HEALTH PERCEPTIONS, PAIN, AND PHYSICAL FUNCTIONING. RESULTS: AT 10 WEEKS, WE DID NOT FIND A STATISTICALLY SIGNIFICANT DIFFERENCE BETWEEN GROUPS IN DEPRESSION SYMPTOMS (B = -0.82, S.E. = 0.88, P = 0.36). HOWEVER, OVER THE ENTIRE INTERVENTION AND FOLLOW-UP PERIOD, WHEN CONTROLLING FOR BASELINE, YOGA PARTICIPANTS SHOWED LOWER LEVELS OF DEPRESSION THAN HLW PARTICIPANTS (B = -1.38, S.E. = 0.57, P = 0.02). AT 6-MONTH FOLLOW-UP, 51% OF YOGA PARTICIPANTS DEMONSTRATED A RESPONSE (50% REDUCTION IN DEPRESSION SYMPTOMS) COMPARED WITH 31% OF HLW PARTICIPANTS (ODDS RATIO = 2.31; P = 0.04). YOGA PARTICIPANTS SHOWED SIGNIFICANTLY BETTER SOCIAL AND ROLE FUNCTIONING AND GENERAL HEALTH PERCEPTIONS OVER TIME. CONCLUSIONS: ALTHOUGH WE DID NOT SEE A DIFFERENCE IN DEPRESSION SYMPTOMS AT THE END OF THE INTERVENTION PERIOD, YOGA PARTICIPANTS SHOWED FEWER DEPRESSION SYMPTOMS OVER THE ENTIRE FOLLOW-UP PERIOD. BENEFITS OF YOGA MAY ACCUMULATE OVER TIME. 2017 10 2681 62 YOGA IN SEDENTARY ADULTS WITH ARTHRITIS: EFFECTS OF A RANDOMIZED CONTROLLED PRAGMATIC TRIAL. OBJECTIVE: TO EVALUATE THE EFFECT OF INTEGRAL-BASED HATHA YOGA IN SEDENTARY PEOPLE WITH ARTHRITIS. METHODS: THERE WERE 75 SEDENTARY ADULTS AGED 18+ YEARS WITH RHEUMATOID ARTHRITIS (RA) OR KNEE OSTEOARTHRITIS RANDOMLY ASSIGNED TO 8 WEEKS OF YOGA (TWO 60-MIN CLASSES AND 1 HOME PRACTICE/WK) OR WAITLIST. POSES WERE MODIFIED FOR INDIVIDUAL NEEDS. THE PRIMARY ENDPOINT WAS PHYSICAL HEALTH [MEDICAL OUTCOMES STUDY SHORT FORM-36 (SF-36) PHYSICAL COMPONENT SUMMARY (PCS)] ADJUSTED FOR BASELINE; EXPLORATORY ADJUSTED OUTCOMES INCLUDED FITNESS, MOOD, STRESS, SELF-EFFICACY, SF-36 HEALTH-RELATED QUALITY OF LIFE (HRQOL), AND RA DISEASE ACTIVITY. IN EVERYONE COMPLETING YOGA, WE EXPLORED LONGTERM EFFECTS AT 9 MONTHS. RESULTS: PARTICIPANTS WERE MOSTLY FEMALE (96%), WHITE (55%), AND COLLEGE-EDUCATED (51%), WITH A MEAN (SD) AGE OF 52 YEARS (12 YRS). AVERAGE DISEASE DURATION WAS 9 YEARS AND 49% HAD RA. AT 8 WEEKS, YOGA WAS ASSOCIATED WITH SIGNIFICANTLY HIGHER PCS (6.5, 95% CI 2.0-10.7), WALKING CAPACITY (125 M, 95% CI 15-235), POSITIVE AFFECT (5.2, 95% CI 1.4-8.9), AND LOWER CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE (-3.0, 95% CI -4.8 - -1.3). SIGNIFICANT IMPROVEMENTS (P < 0.05) WERE EVIDENT IN SF-36 ROLE PHYSICAL, PAIN, GENERAL HEALTH, VITALITY, AND MENTAL HEALTH SCALES. BALANCE, GRIP STRENGTH, AND FLEXIBILITY WERE SIMILAR BETWEEN GROUPS. TWENTY-TWO OUT OF 28 IN THE WAITLIST GROUP COMPLETED YOGA. AMONG ALL YOGA PARTICIPANTS, SIGNIFICANT (P < 0.05) IMPROVEMENTS WERE OBSERVED IN MEAN PCS, FLEXIBILITY, 6-MIN WALK, AND ALL PSYCHOLOGICAL AND MOST HRQOL DOMAINS AT 8 WEEKS WITH MOST STILL EVIDENT 9 MONTHS LATER. OF 7 ADVERSE EVENTS, NONE WERE ASSOCIATED WITH YOGA. CONCLUSION: PRELIMINARY EVIDENCE SUGGESTS YOGA MAY HELP SEDENTARY INDIVIDUALS WITH ARTHRITIS SAFELY INCREASE PHYSICAL ACTIVITY, AND IMPROVE PHYSICAL AND PSYCHOLOGICAL HEALTH AND HRQOL. CLINICAL TRIALS NCT00349869. 2015 11 594 39 DEVELOPMENT AND FEASIBILITY OF A GROUP-BASED THERAPEUTIC YOGA PROGRAM FOR WOMEN WITH CHRONIC PELVIC PAIN. OBJECTIVE: TO DEVELOP A GROUP-BASED THERAPEUTIC YOGA PROGRAM FOR WOMEN WITH CHRONIC PELVIC PAIN (CPP) AND EXPLORE THE EFFECTS OF THIS PROGRAM ON PAIN SEVERITY, SEXUAL FUNCTION, AND WELL-BEING. METHODS: A YOGA THERAPY PROGRAM FOR CPP WAS DEVELOPED BY A MULTIDISCIPLINARY PANEL OF CLINICIANS, RESEARCHERS, AND YOGA CONSULTANTS. WOMEN REPORTING MODERATE TO SEVERE PELVIC PAIN FOR AT LEAST SIX MONTHS WERE RECRUITED INTO A SINGLE-ARM TRIAL. PARTICIPANTS ATTENDED TWICE WEEKLY GROUP CLASSES FOCUSING ON IYENGAR-BASED YOGA TECHNIQUES AND WERE INSTRUCTED TO PRACTICE YOGA AT HOME AN HOUR A WEEK FOR SIX WEEKS. PARTICIPANTS SELF-RATED THE SEVERITY OF THEIR PELVIC PAIN USING DAILY LOGS. THE IMPACT OF PARTICIPANTS' PAIN ON EVERYDAY ACTIVITIES, EMOTIONAL WELL-BEING, AND SEXUAL FUNCTION WAS ASSESSED USING AN IMPACT OF PELVIC PAIN (IPP) QUESTIONNAIRE. SEXUAL FUNCTION WAS FURTHER ASSESSED USING THE SEXUAL HEALTH OUTCOMES IN WOMEN QUESTIONNAIRE (SHOW-Q). RESULTS: AMONG THE 16 PARTICIPANTS (AGE RANGE = 31-64 YEARS), AVERAGE RATINGS OF THE SEVERITY OF PAIN "AT ITS WORST," "AT ITS BEST," AND "ON AVERAGE" DECREASED BY 29%, 32%, AND 34%, RESPECTIVELY, FROM START TO SIX WEEKS (P < 0.05 FOR ALL). WOMEN DEMONSTRATED IMPROVEMENTS IN SCORES ON IPP SUBSCALES FOR DAILY ACTIVITIES (1.8 +/- 0.7 TO 0.9 +/- 0.7, P < 0.001), EMOTIONAL WELL-BEING (1.7 +/- 0.9 TO 0.9 +/- 0.7, P = 0.005), AND SEXUAL FUNCTION (1.9 +/- 1.1 TO 1.0 +/- 0.9, P = 0.04). SCORES ON THE SHOW-Q "PELVIC PROBLEM INTERFERENCE" SCALE ALSO IMPROVED OVER SIX WEEKS (53 +/- 23 TO 27 +/- 23, P = 0.002). CONCLUSIONS: FINDINGS PROVIDE PRELIMINARY EVIDENCE OF THE FEASIBILITY OF TEACHING WOMEN WITH CPP TO PRACTICE YOGA TO SELF-MANAGE PAIN AND IMPROVE QUALITY OF LIFE AND SEXUAL FUNCTION. 2017 12 1228 43 FEASIBILITY AND IMPACT OF A YOGA INTERVENTION ON COGNITION, PHYSICAL FUNCTION, PHYSICAL ACTIVITY, AND AFFECTIVE OUTCOMES AMONG PEOPLE LIVING WITH HIV: A RANDOMIZED CONTROLLED PILOT TRIAL. THE PURPOSE OF THIS PILOT RANDOMIZED CONTROLLED TRIAL IS TO ASSESS THE FEASIBILITY AND IMPACT OF A TRIWEEKLY 12-WEEK YOGA INTERVENTION AMONG PEOPLE LIVING WITH HIV (PLWH). ADDITIONAL OBJECTIVES INCLUDED EVALUATING COGNITION, PHYSICAL FUNCTION, MEDICATION ADHERENCE, HEALTH-RELATED QUALITY OF LIFE (HRQOL), AND MENTAL HEALTH AMONG YOGA PARTICIPANTS VERSUS CONTROLS USING BLINDED ASSESSORS. WE RECRUITED 22 MEDICALLY STABLE PLWH AGED >/=35 YEARS. A PRIORI FEASIBILITY CRITERIA WERE >/=70% YOGA SESSION ATTENDANCE AND >/=70% OF PARTICIPANTS SATISFIED WITH THE INTERVENTION USING A POSTPARTICIPATION QUESTIONNAIRE. TWO PARTICIPANTS WITHDREW FROM THE YOGA GROUP. MEAN YOGA CLASS ATTENDANCE WAS 82%, WITH 100% SATISFACTION. INTENTION-TO-TREAT ANALYSES (YOGA N = 11, CONTROL N = 11) SHOWED NO WITHIN- OR BETWEEN-GROUP DIFFERENCES IN COGNITIVE AND PHYSICAL FUNCTION. THE YOGA GROUP IMPROVED OVER TIME IN HRQOL COGNITION (P = .047) WITH TRENDS TOWARD IMPROVEMENTS IN HRQOL HEALTH TRANSITION (P =.063) AND DEPRESSION (P = .055). THIS PILOT STUDY PROVIDES PRELIMINARY EVIDENCE OF FEASIBILITY AND BENEFITS OF YOGA FOR PLWH. 2020 13 1585 49 MEDICAL YOGA FOR PATIENTS WITH STRESS-RELATED SYMPTOMS AND DIAGNOSES IN PRIMARY HEALTH CARE: A RANDOMIZED CONTROLLED TRIAL. AN INCREASING NUMBER OF PATIENTS ARE SUFFERING FROM STRESS-RELATED SYMPTOMS AND DIAGNOSES. THE PURPOSE OF THIS STUDY WAS TO EVALUATE THE MEDICAL YOGA TREATMENT IN PATIENTS WITH STRESS-RELATED SYMPTOMS AND DIAGNOSES IN PRIMARY HEALTH CARE. A RANDOMIZED CONTROLLED STUDY WAS PERFORMED AT A PRIMARY HEALTH CARE CENTRE IN SWEDEN FROM MARCH TO JUNE, 2011. PATIENTS WERE RANDOMLY ALLOCATED TO A CONTROL GROUP RECEIVING STANDARD CARE OR A YOGA GROUP TREATED WITH MEDICAL YOGA FOR 1 HOUR, ONCE A WEEK, OVER A 12-WEEK PERIOD IN ADDITION TO THE STANDARD CARE. A TOTAL OF 37 MEN AND WOMEN, MEAN AGE OF 53 +/- 12 YEARS WERE INCLUDED. GENERAL STRESS LEVEL (MEASURED USING PERCEIVED STRESS SCALE (PSS)), BURNOUT (SHIROM-MELAMED BURNOUT QUESTIONNAIRE (SMBQ)), ANXIETY AND DEPRESSION (HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS)), INSOMNIA SEVERITY (INSOMNIA SEVERITY INDEX (ISI)), PAIN (VISUAL ANALOGUE SCALE (VAS)), AND OVERALL HEALTH STATUS (EURO QUALITY OF LIFE VAS (EQ-VAS)) WERE MEASURED BEFORE AND AFTER 12 WEEKS. PATIENTS ASSIGNED TO THE YOGA GROUP SHOWED SIGNIFICANTLY GREATER IMPROVEMENTS ON MEASURES OF GENERAL STRESS LEVEL (P < 0.000), ANXIETY (P < 0.019), AND OVERALL HEALTH STATUS (P < 0.018) COMPARED TO CONTROLS. TREATMENT WITH MEDICAL YOGA IS EFFECTIVE IN REDUCING LEVELS OF STRESS AND ANXIETY IN PATIENTS WITH STRESS-RELATED SYMPTOMS IN PRIMARY HEALTH CARE. 2013 14 1841 42 QIGONG OR YOGA VERSUS NO INTERVENTION IN OLDER ADULTS WITH CHRONIC LOW BACK PAIN-A RANDOMIZED CONTROLLED TRIAL. UNLABELLED: THE AIM OF THIS STUDY WAS TO ASSESS THE EFFECTIVENESS OF THE REDUCTION OF CHRONIC LOWER BACK PAIN IN OLDER ADULTS USING EITHER YOGA CLASSES OR QIGONG CLASSES COMPARED WITH NO INTERVENTION. OLDER ADULTS (65 YEARS OF AGE AND OLDER) WITH CHRONIC LOW BACK PAIN WERE ENROLLED IN AND RANDOMLY ALLOCATED TO: 1) YOGA (24 CLASSES, 45 MINUTES EACH, DURING 3 MONTHS), 2) QIGONG (12 CLASSES, 90 MINUTES EACH, DURING 3 MONTHS), OR 3) A CONTROL GROUP WHO RECEIVED NO ADDITIONAL INTERVENTION. THE PAIN INTENSITY ITEM OF THE FUNCTIONAL RATING INDEX AFTER 3 MONTHS WAS USED AS PRIMARY OUTCOME PARAMETER. A TOTAL OF 176 PATIENTS WERE RANDOMIZED (N = 61 YOGA, N = 58 QIGONG, N = 57 CONTROL; MEAN AGE 73 +/- 5.6 YEARS, 89% FEMALE). THE MEAN ADJUSTED PAIN INTENSITY AFTER 3 MONTHS WAS 1.71 FOR THE YOGA GROUP (95% CONFIDENCE INTERVAL [CI], 1.54-1.89), 1.67 FOR THE QIGONG GROUP (95% CI, 1.45-1.89), AND 1.89 FOR NO INTERVENTION (95% CI, 1.67-2.11). NO STATISTICALLY SIGNIFICANT GROUP DIFFERENCES WERE OBSERVED. POSSIBLE EXPLANATIONS FOR THIS LACK OF PAIN RELIEF MIGHT INCLUDE THE INEFFECTIVENESS OF INTERVENTIONS, INAPPROPRIATE OUTCOMES, OR DIFFERENCES IN PAIN PERCEPTION AND PROCESSING IN OLDER ADULTS. PERSPECTIVE: THE AIM OF THIS STUDY WAS TO ASSESS THE EFFECTIVENESS OF THE REDUCTION OF CHRONIC LOWER BACK PAIN IN OLDER ADULTS USING EITHER YOGA CLASSES OR QIGONG CLASSES COMPARED WITH NO INTERVENTION. THIS 3-ARMED RANDOMIZED TRIAL WITH 176 OLDER ADULTS SHOWED THAT YOGA AND QIGONG WERE NOT SUPERIOR TO NO TREATMENT IN REDUCING PAIN AND INCREASING QUALITY OF LIFE. 2016 15 2653 54 YOGA IMPROVES OCCUPATIONAL PERFORMANCE, DEPRESSION, AND DAILY ACTIVITIES FOR PEOPLE WITH CHRONIC PAIN. BACKGROUND: CHRONIC PAIN IS A COMPLEX ACCUMULATION OF PHYSICAL, PSYCHOLOGICAL, AND SOCIAL CONDITIONS, THUS INTERVENTIONS THAT ADDRESS PAIN AND PROMOTE OCCUPATIONAL PERFORMANCE ARE NEEDED. A HOLISTIC INTERVENTION, WITH MIND AND BODY COMPONENTS, IS LIKELY NECESSARY TO BEST TREAT THE COMPLEXITIES OF CHRONIC PAIN. THUS, WE DEVELOPED AND TESTED A YOGA INTERVENTION FOR PEOPLE WITH CHRONIC PAIN. OBJECTIVES: IN A RANDOMIZED CONTROL TRIAL (RCT), PARTICIPANTS WITH CHRONIC PAIN WERE RANDOMIZED TO A YOGA INTERVENTION OR USUAL CARE GROUP. BETWEEN AND WITHIN GROUP DIFFERENCES FOR PRE-AND POST-OUTCOME MEASURE SCORES WERE ASSESSED FOR: OCCUPATIONAL PERFORMANCE, COMPLETION OF ACTIVITIES, AND DEPRESSION. METHODS: PILOT RCT WITH PARTICIPANT ALLOCATION TO 8 WEEKS OF YOGA OR USUAL CARE. BOTH GROUPS RECEIVED ONGOING MONTHLY SELF-MANAGEMENT PROGRAMMING. DATA WERE COLLECTED BEFORE AND AFTER THE 8-WEEK INTERVENTION. PARTICIPANTS WERE RANDOMIZED TO YOGA OR USUAL CARE AFTER BASELINE ASSESSMENTS. DEMOGRAPHICS WERE COLLECTED AND MEASURES INCLUDED: CANADIAN OCCUPATIONAL PERFORMANCE MEASURE (COPM) TO ASSESS OCCUPATIONAL PERFORMANCE; THE 15-ITEM FRENCHAY ACTIVITIES INDEX (FAI)(ACTIVITIES); AND THE 9-ITEM PATIENT HEALTH QUESTIONNAIRE (PHQ-9) FOR DEPRESSION. INDEPENDENT T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN GROUPS. PAIRED T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN PRE- AND POST 8-WEEK INTERVENTION FOR BOTH THE YOGA AND THE USUAL CARE GROUPS. PERCENT CHANGE SCORES AND EFFECT SIZES WERE CALCULATED. RESULTS: 83 PEOPLE WERE RECRUITED FOR THE STUDY AND COMPLETED BASELINE ASSESSMENTS; 44 INDIVIDUALS WERE RANDOMIZED TO YOGA AND 39 TO THE CONTROL GROUP. THE AVERAGE AGE OF ALL PARTICIPANTS WAS 51.4+/-10.5 YEARS, 68% WERE FEMALE; AND 60% HAD AT LEAST SOME COLLEGE EDUCATION. THERE WERE NO SIGNIFICANT DIFFERENCES IN DEMOGRAPHICS OR OUTCOME MEASURES BETWEEN GROUPS AT BASELINE OR 8 WEEKS; HOWEVER, THE STUDY WAS NOT POWERED TO SEE SUCH DIFFERENCES. INDIVIDUALS RANDOMIZED TO THE CONTROL GROUP DID NOT SIGNIFICANTLY IMPROVE IN ANY OUTCOME MEASURE OVER THE 8 WEEKS. THERE WERE SIGNIFICANT IMPROVEMENTS IN COPM PERFORMANCE AND COPM SATISFACTION SCORES FOR INDIVIDUALS RANDOMIZED TO THE YOGA GROUP; BOTH SCORES SIGNIFICANTLY IMPROVED. COPM PERFORMANCE IMPROVED BY 27% WITH A MODERATE TO LARGE EFFECT SIZE (3.66+/-1.85 VS 4.66+/-1.93, P < 0.001, D = 0.76). COPM SATISFACTION SIGNIFICANTLY IMPROVED BY 78% (2.14+/-2.31 VS. 3.80+/-2.50, P < 0.001) AND HAD A LARGE EFFECTS SIZE (D = 1.02). FAI SCORES IMPROVED, INDICATING INCREASED ACTIVITY OR ENGAGEMENT IN DAILY OCCUPATION DURING THE 8-WEEK INTERVENTION. SCORES INCREASED BY 5% (38.13+/-8.48 VS. 39.90+/-8.57, P = 0.024) WITH A SMALL EFFECT SIZE (D = 0.37). DEPRESSION SIGNIFICANTLY DECREASED FROM 13.21+/-5.60 TO 11.41+/-5.82, P = 0.041, WITH A SMALL EFFECT SIZE. CONCLUSION: DATA FROM THIS PILOT RCT INDICATE YOGA MAY BE AN EFFECTIVE THERAPEUTIC INTERVENTION WITH PEOPLE IN CHRONIC PAIN TO IMPROVE OCCUPATIONAL PERFORMANCE, INCREASE ENGAGEMENT IN ACTIVITIES, AND DECREASE DEPRESSION. OCCUPATIONAL THERAPY PRACTITIONERS MAY CONSIDER ADDING YOGA AS A TREATMENT INTERVENTION TO ADDRESS THE NEEDS OF PEOPLE WITH PAIN. 2019 16 171 56 A RANDOMIZED CONTROLLED PILOT STUDY OF THE THERAPEUTIC EFFECTS OF YOGA IN PEOPLE WITH PARKINSON'S DISEASE. BACKGROUND: EXERCISE CAN BE BENEFICIAL FOR CARDIOPULMONARY, MUSCULOSKELETAL OR NEUROLOGICAL SYSTEMS, AND OTHER FACTORS INCLUDING MOOD, AND MAY BE BENEFICIAL IN REDUCING FALL RISKS, DEMENTIA AND VARIABLES ASSOCIATED WITH QUALITY OF LIFE (QOL). PARKINSON'S DISEASE (PD) PRODUCES PROGRESSIVE MOTOR AND COGNITIVE DETERIORATION THAT MAY LEAVE THOSE INFLICTED UNABLE TO PARTICIPATE IN STANDARD EXERCISE PROGRAMS. ALTERNATIVE FORMS OF EXERCISE SUCH AS YOGA MAY BE SUCCESSFUL IN IMPROVING PHYSICAL FUNCTION, QOL AND PHYSIOLOGICAL VARIABLES FOR OVERALL WELL-BEING. AIM: THIS RANDOMIZED CONTROLLED PILOT STUDY INVESTIGATED THE EFFECTIVENESS OF YOGA INTERVENTION ON PHYSIOLOGICAL AND HEALTH-RELATED QOL MEASURES IN PEOPLE WITH PD. METHODS AND MATERIALS: THIRTEEN PEOPLE WITH STAGE 1-2 PD WERE RANDOMIZED TO EITHER A YOGA (N = 8) OR A CONTROL GROUP (N = 5). THE YOGA GROUP PARTICIPATED IN TWICE-WEEKLY YOGA SESSIONS FOR 12 WEEKS. PARTICIPANTS WERE TESTED AT BASELINE, AND AT 6 AND 12 WEEKS USING THE UNIFIED PARKINSON'S DISEASE RATING SCALE (UPDRS), CLINICAL MEASURES OF HEALTH-RELATED QOL AND PHYSIOLOGICAL MEASURES. RESULTS: SIGNIFICANT IMPROVEMENT IN UPDRS SCORES (P = .006), DIASTOLIC BLOOD PRESSURE (P = 0.036) AND AVERAGE FORCED VITAL CAPACITY (P = 0.03) WAS NOTED IN THE YOGA GROUP OVER TIME. CHANGES BETWEEN GROUPS WERE ALSO NOTED IN TWO SF-36 SUBSCALES. POSITIVE TRENDS OF IMPROVEMENT WERE NOTED IN DEPRESSION SCORES (P = 0.056), BODY WEIGHT (P = 0.056) AND FORCED EXPIRATORY VOLUME (P = 0.059). YOGA PARTICIPANTS REPORTED MORE POSITIVE SYMPTOM CHANGES INCLUDING IMMEDIATE TREMOR REDUCTION. CONCLUSIONS: THE RESULTS SUGGEST THAT YOGA MAY IMPROVE ASPECTS OF QOL AND PHYSIOLOGICAL FUNCTIONS IN STAGES 1-2 PD. FUTURE LARGER STUDIES ARE NEEDED TO CONFIRM AND EXTEND OUR FINDINGS OF THE EFFECTS OF YOGA IN PD. 2015 17 1448 29 INDIVIDUALLY TAILORED YOGA FOR CHRONIC NECK OR BACK PAIN IN A LOW-INCOME POPULATION: A PILOT STUDY. BACKGROUND: LOW-INCOME PEOPLE ARE DISPROPORTIONATELY AFFECTED BY CHRONIC BACK AND NECK PAIN. YOGA MAY BE AN EFFECTIVE THERAPY. AIMS: THIS FEASIBILITY PILOT STUDY EVALUATED AN INDIVIDUALIZED YOGA PLAN FOR THE TREATMENT OF CHRONIC SPINAL PAIN. METHODS: RESULTS: INDIVIDUALS SHOWED A MEAN CHANGE OF -2.4 FROM PRE/POST 10-CM PAIN SCALE RECORDINGS (P = 0.028, 95% CONFIDENCE INTERVAL [CI]: -0.390--4.477) AND A MEAN INCREASE OF 0.26 ON THE EQ-5D-3L (P = 0.029, 95% CI: 0.04-0.47). THE INTERVENTION WAS WELL-RECEIVED. CONCLUSIONS: AN INDIVIDUALLY TAILORED YOGA PROGRAM WAS ACCEPTABLE TO THESE PARTICIPANTS. PAIN AND QUALITY OF LIFE SCORES APPEARED TO IMPROVE. 2020 18 2549 54 YOGA FOR CANCER SURVIVORS WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY: HEALTH-RELATED QUALITY OF LIFE OUTCOMES. BACKGROUND: YOGA IS A MEDITATIVE MOVEMENT THERAPY FOCUSED ON MIND-BODY AWARENESS. THE IMPACT OF YOGA ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) OUTCOMES IN PATIENTS WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN) IS UNCLEAR. METHODS: WE CONDUCTED A PILOT RANDOMIZED WAIT-LIST CONTROLLED TRIAL OF 8 WEEKS OF YOGA (N = 21) VERSUS WAIT-LIST CONTROL (N = 20) FOR CIPN IN 41 BREAST AND GYNECOLOGICAL CANCER SURVIVORS WITH PERSISTENT MODERATE TO SEVERE CIPN. HRQOL ENDPOINTS WERE HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS), BRIEF FATIGUE INVENTORY (BFI), AND INSOMNIA SEVERITY INDEX (ISI). THE TREATMENT EXPECTANCY SCALE (TES) WAS ADMINISTERED AT BASELINE. WE ESTIMATED MEAN CHANGES AND 95% CONFIDENCE INTERVALS (CIS) FROM BASELINE TO WEEKS 8 AND 12 AND COMPARED ARMS USING CONSTRAINED LINEAR MIXED MODELS. RESULTS: AT WEEK 8, HADS ANXIETY SCORES DECREASED -1.61 (-2.75, -0.46) IN THE YOGA ARM AND -0.32 (-1.38, 0.75) POINTS IN THE WAIT-LIST CONTROL ARM (P = 0.099). AT WEEK 12, HADS ANXIETY SCORES DECREASED -1.42 (-2.57, -0.28) IN YOGA COMPARED TO AN INCREASE OF 0.46 (-0.60, 1.53) IN WAIT-LIST CONTROL (P = 0.017). THERE WERE NO SIGNIFICANT DIFFERENCES IN HADS DEPRESSION, BFI, OR ISI SCORES BETWEEN YOGA AND WAIT-LIST CONTROL. BASELINE TES WAS SIGNIFICANTLY HIGHER IN YOGA THAN IN WAIT-LIST CONTROL (14.9 VS. 12.7, P = 0.019). TES WAS NOT ASSOCIATED WITH HADS ANXIETY REDUCTION AND HADS ANXIETY REDUCTION WAS NOT ASSOCIATED WITH CIPN PAIN REDUCTION. CONCLUSIONS: YOGA MAY REDUCE ANXIETY IN PATIENTS WITH CIPN. FUTURE STUDIES ARE NEEDED TO CONFIRM THESE FINDINGS. CLINICAL TRIAL REGISTRATION NUMBER: CLINICALTRIALS.GOV IDENTIFIER: NCT03292328. 2021 19 1072 72 EFFECTS OF YOGA ON OXIDATIVE STRESS, MOTOR FUNCTION, AND NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE: A PILOT RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: TO EXAMINE THE FEASIBILITY, ACCEPTABILITY, AND PRELIMINARY EFFECTS OF HATHA YOGA ON OXIDATIVE STRESS, MOTOR FUNCTION, AND NON-MOTOR SYMPTOMS AMONG INDIVIDUALS WITH PARKINSON'S DISEASE (PD). METHODS: THE STUDY HAS A PILOT RANDOMIZED CONTROLLED TRIAL DESIGN WITH TWO ARMS: AN IMMEDIATE TREATMENT GROUP AND A WAIT-LIST CONTROL GROUP. THE YOGA-FOR-PD PROGRAM WAS IMPLEMENTED VIA TWICE WEEKLY 60-MIN GROUP-BASED CLASSES FOR 12 WEEKS. PARTICIPANTS WERE ASSESSED AT BASELINE, 12 WEEKS, AND 6 MONTHS POST-INTERVENTION. OUTCOME MEASURES INCLUDED OXIDATIVE STRESS, MOTOR FUNCTION, PHYSICAL ACTIVITY, COGNITIVE FUNCTION, SLEEP QUALITY, AND QUALITY OF LIFE. DATA ON PROGRAM ACCEPTABILITY AND YOGA ADHERENCE WERE COLLECTED DURING THE INTERVENTION AND AT 6 MONTHS POST-INTERVENTION. RESULTS: PARTICIPANTS (N = 20) HAD A MEAN AGE OF 63 YEARS (SD 8, RANGE 49-75) AND DISEASE DURATION 4.8 YEARS (SD 2.9, RANGE 1-13). ALL PARTICIPANTS HAD MILD-MODERATE DISEASE SEVERITY; 18 (90%) WERE ON DOPAMINERGIC MEDICATIONS. SEVENTEEN PARTICIPANTS (85%) ATTENDED AT LEAST 75% OF THE CLASSES AND 4 (20%) ATTENDED ALL CLASSES. MOST PARTICIPANTS (N = 17) REPORTED THEY "DEFINITELY ENJOYED" THE INTERVENTION PROGRAM. NO ADVERSE EVENTS WERE REPORTED. AT 12 WEEKS, THERE WERE NO MAJOR DIFFERENCES IN BLOOD OXIDATIVE STRESS MARKERS BETWEEN THE TWO GROUPS. MOTOR FUNCTION BASED ON THE UNIFIED PARKINSON'S DISEASE RATING SCALE WAS BETTER IN THE TREATMENT GROUP, BUT THEIR SCORES ON SLEEP AND OUTLOOK IN PARKINSON'S DISEASE QUALITY OF LIFE (PDQUALIF) SCALE AND THE PHYSICAL ACTIVITY LEVELS BASED ON THE LONGITUDINAL AGING STUDY AMSTERDAM PHYSICAL ACTIVITY QUESTIONNAIRE WERE WORSE THAN THOSE OF THE CONTROL GROUP. IN WITHIN-GROUP COMPARISONS, MOTOR FUNCTION, COGNITIVE FUNCTION, AND CATALASE IMPROVED BUT THREE PDQUALIF DOMAINS (SOCIAL AND ROLE FUNCTION, SLEEP, AND OUTLOOK) AND PHYSICAL ACTIVITY LEVEL WORSENED BY THE END OF THE YOGA INTERVENTION PROGRAM COMPARED TO BASELINE. THE RESPONSE RATE FOR THE 6-MONTH FOLLOW-UP SURVEY WAS 74% (N = 14) WITH SIX PARTICIPANTS (43%) WHO SIGNED UP FOR A YOGA CLASS AND FOUR (29%) WHO PRACTICED IT INDEPENDENTLY. HEALTH PROBLEMS WERE THE MAIN BARRIER TO YOGA PRACTICE. CONCLUSION: YOGA IS FEASIBLE AND ACCEPTABLE AND MAY SERVE AS A COMPLEMENTARY METHOD FOR IMPROVING MOTOR FUNCTION IN PD. FURTHER RESEARCH USING A LARGER SAMPLE SIZE IS NEEDED TO DETERMINE ITS IMPACT ON OXIDATIVE STRESS AND NON-MOTOR SYMPTOMS. TRIAL REGISTRATION: CLINICALTRIALS.GOV REGISTRATION NUMBER: NCT02509610031. 2018 20 167 54 A RANDOMIZED CONTROLLED BICENTER TRIAL OF YOGA FOR PATIENTS WITH COLORECTAL CANCER. OBJECTIVE: THE AIM OF THIS TRIAL WAS TO EVALUATE THE EFFECTS OF YOGA ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH COLORECTAL CANCER. METHODS: PATIENTS WITH NON-METASTATIC COLORECTAL CANCER WERE RANDOMLY ASSIGNED TO A 10-WEEK YOGA INTERVENTION (90 MIN ONCE WEEKLY) OR A WAITLIST CONTROL GROUP. PRIMARY OUTCOME MEASURE WAS DISEASE-SPECIFIC QUALITY OF LIFE (FUNCTIONAL ASSESSMENT OF CANCER THERAPY - COLORECTAL [FACT-C]) AT WEEK 10. SECONDARY OUTCOME MEASURES INCLUDED FACT-C SUBSCALES: SPIRITUAL WELL-BEING (FACT - SPIRITUALITY); FATIGUE (FACT - FATIGUE); SLEEP DISTURBANCES (PITTSBURGH SLEEP QUALITY INVENTORY); DEPRESSION AND ANXIETY (HOSPITAL ANXIETY AND DEPRESSION SCALE); BODY AWARENESS (SCALE OF BODY CONNECTION); AND BODY-EFFICACY EXPECTATIONS (BODY-EFFICACY EXPECTATIONS SCALE). OUTCOMES WERE ASSESSED AT WEEK 10 AND WEEK 22 AFTER RANDOMIZATION. RESULTS: FIFTY-FOUR PATIENTS (MEAN AGE 68.3 +/- 9.7 YEARS) WERE RANDOMIZED TO YOGA (N = 27; ATTRITION RATE 22.2%) AND CONTROL GROUP (N = 27; ATTRITION RATE 18.5%). PATIENTS IN THE YOGA GROUP ATTENDED A MEAN OF 5.3 +/- 4.0 YOGA CLASSES. NO SIGNIFICANT GROUP DIFFERENCES FOR THE FACT-C TOTAL SCORE WERE FOUND. GROUP DIFFERENCES WERE FOUND FOR EMOTIONAL WELL-BEING AT WEEK 22 ( = 1.59; 95% CI = 0.27,2.90; P = 0.019), SLEEP DISTURBANCES AT WEEK 22 ( = -1.08; 95% CI = -2.13, -0.03; P = 0.043), ANXIETY AT WEEK 10 ( = -1.14; 95% CI = -2.20, -0.09; P = 0.043), AND DEPRESSION AT WEEK 10 ( = -1.34; 95% CI = -2.61, -0.8; P = 0.038). NO SERIOUS ADVERSE EVENTS OCCURRED IN THE YOGA GROUP, WHILE LIVER METASTASES WERE DIAGNOSED IN ONE PATIENT IN THE CONTROL GROUP. CONCLUSION: THIS RANDOMIZED TRIAL FOUND NO EFFECTS OF YOGA ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH COLORECTAL CANCER. GIVEN THE HIGH ATTRITION RATE AND LOW INTERVENTION ADHERENCE, NO DEFINITE CONCLUSIONS CAN BE DRAWN FROM THIS TRIAL. 2016